BioXcel Therapeutics Inc (BTAI)
2.77
+0.22
(+8.63%)
USD |
NASDAQ |
Apr 19, 16:00
2.75
-0.02
(-0.72%)
After-Hours: 20:00
BioXcel Therapeutics Total Long Term Debt (Quarterly): 100.60M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 100.60M |
| September 30, 2023 | 99.09M |
| June 30, 2023 | 96.85M |
| Date | Value |
|---|---|
| March 31, 2023 | 95.06M |
| December 31, 2022 | 93.05M |
| September 30, 2022 | 91.70M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
91.70M
Minimum
Sep 2022
100.60M
Maximum
Dec 2023
96.06M
Average
95.95M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Synlogic Inc | 0.00 |
| Cormedix Inc | -- |
| Bristol-Myers Squibb Co | 39.77B |
| Verastem Inc | -- |
| Ocular Therapeutix Inc | 74.92M |